Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo-controlled study in healthy adults.
Saved in:
| Title: | Assessment of pharmacokinetic and pharmacodynamic interactions between zavegepant and sumatriptan: A phase 1, randomized, placebo-controlled study in healthy adults. |
|---|---|
| Authors: | Bhardwaj R; Certara USA, Princeton, New Jersey, USA., Donohue MK; Biohaven Pharmaceuticals Inc., New Haven, Connecticut, USA., Madonia J; Biohaven Pharmaceuticals Inc., New Haven, Connecticut, USA., Matschke K; Pfizer Inc., Collegeville, Pennsylvania, USA., Anderson MS; Certara USA, Princeton, New Jersey, USA., Morris B; Biohaven Pharmaceuticals Inc., New Haven, Connecticut, USA., Bertz R; Biohaven Pharmaceuticals Inc., New Haven, Connecticut, USA., Croop R; Biohaven Pharmaceuticals Inc., New Haven, Connecticut, USA., Liu J; Pfizer Inc., Groton, Connecticut, USA. |
| Source: | Headache [Headache] 2025 Feb; Vol. 65 (2), pp. 315-325. Date of Electronic Publication: 2024 Oct 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 2985091R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-4610 (Electronic) Linking ISSN: 00178748 NLM ISO Abbreviation: Headache Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1526-4610 |
|---|---|
| DOI: | 10.1111/head.14853 |
